These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24314668)

  • 1. Comparing PANSS scores and corresponding CGI scores between stable and acute schizophrenic patients.
    Ortiz BB; Pitta JC; Gadelha A; Mattos NF; Cunha JY; de Araújo Filho GM; Cordeiro Q; Belangero SI; Bressan RA
    Schizophr Res; 2014 Jan; 152(1):307-8. PubMed ID: 24314668
    [No Abstract]   [Full Text] [Related]  

  • 2. Anhedonia in acute schizophrenia.
    Sarkar S; Praharaj SK; Chaudhury S; Das B
    Afr J Psychiatry (Johannesbg); 2010 Jul; 13(3):226-7. PubMed ID: 20957322
    [No Abstract]   [Full Text] [Related]  

  • 3. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
    Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
    Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients.
    Huber CG; Lambert M; Naber D; Schacht A; Hundemer HP; Wagner TT; Schimmelmann BG
    Schizophr Res; 2008 Mar; 100(1-3):342-8. PubMed ID: 18255271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.
    Levine SZ; Rabinowitz J; Engel R; Etschel E; Leucht S
    Schizophr Res; 2008 Jan; 98(1-3):318-22. PubMed ID: 17949948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.
    Glick HA; Li P; Harvey PD
    Schizophr Res; 2015 Aug; 166(1-3):110-4. PubMed ID: 26044113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking the PANSS, BPRS, and CGI: clinical implications.
    Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
    Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients.
    Fresán A; De la Fuente-Sandoval C; Loyzaga C; García-Anaya M; Meyenberg N; Nicolini H; Apiquian R
    Schizophr Res; 2005 Jan; 72(2-3):123-9. PubMed ID: 15560957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Taiwanese Mandarin version of the Personal and Social Performance scale in a sample of 655 stable schizophrenic patients.
    Wu BJ; Lin CH; Tseng HF; Liu WM; Chen WC; Huang LS; Sun HJ; Chiang SK; Lee SM
    Schizophr Res; 2013 May; 146(1-3):34-9. PubMed ID: 23478156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia.
    Fan X; Liu E; Pristach C; Goff DC; Henderson DC
    Schizophr Res; 2006 Sep; 86(1-3):30-5. PubMed ID: 16750348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
    Moukas G; Stathopoulou A; Gourzis P; Beratis IN; Beratis S
    Compr Psychiatry; 2010; 51(1):1-7. PubMed ID: 19932819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated eye movement score as a neurophysiological marker of schizophrenia.
    Miura K; Hashimoto R; Fujimoto M; Yamamori H; Yasuda Y; Ohi K; Umeda-Yano S; Fukunaga M; Iwase M; Takeda M
    Schizophr Res; 2014 Dec; 160(1-3):228-9. PubMed ID: 25458574
    [No Abstract]   [Full Text] [Related]  

  • 15. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
    Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the PANSS items most related with global improvements in patients with schizophrenia? Toward a reduced version of the PANSS.
    Ortiz BB; Gadelha A; Higuchi CH; Pitta JC; Kagan S; Vong MR; Noto C; Hallak JE; Bressan RA
    Schizophr Res; 2014 Sep; 158(1-3):277-8. PubMed ID: 25008793
    [No Abstract]   [Full Text] [Related]  

  • 18. Computerized self-assessment of psychosis severity questionnaire [COSAPSQ] in schizophrenia: preliminary results.
    Stern RG; Fudge R; Sison CE; Allan ER; Crichton J; Losonczy M
    Psychopharmacol Bull; 1998; 34(1):9-12. PubMed ID: 9564192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equipercentile linking of the BPRS and the PANSS.
    Leucht S; Rothe P; Davis JM; Engel RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.